MTND6P6

Across TCGA pan-cancer cohorts, MTND6P6 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MTND6P6 data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher MTND6P6 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MTND6P6 expression acts as an unfavorable survival marker.

THCA, UCEC, and ESCA are the cancer types where MTND6P6 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.032	0.950	<.001	144	view →
UCEC	OS	Tertile	III,IV	0.081	0.601	<.001	78	view →
ESCA	OS	Tertile	All	0.198	0.872	.003	36	view →
OV	OS	Tertile	IV	0.028	0.759	.002	36	view →
HNSC	DFS	Tertile	All	0.163	0.710	.008	36	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MTND6P6–THCA (OS)

Open the THCA breakdown →